L

Lexicon Pharmaceuticals
D

LXRX

0.91110
USD
0.00
(0.02%)
مغلق
حجم التداول
36,838
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
330,891,476
أصول ذات صلة
ABBV
ABBV
-1.530
(-0.80%)
189.200 USD
AMGN
AMGN
1.79
(0.60%)
298.52 USD
BMY
BMY
-0.525
(-1.10%)
47.080 USD
GSK
GSK
-0.285
(-0.74%)
38.220 USD
JNJ
JNJ
0.570
(0.37%)
156.110 USD
LLY
LLY
0.55
(0.07%)
779.65 USD
MRK
MRK
-1.370
(-1.66%)
81.010 USD
NVO
NVO
-0.660
(-0.95%)
69.140 USD
PFE
PFE
0.110
(0.43%)
25.440 USD
REGN
REGN
-0.69
(-0.13%)
546.88 USD
المزيد
الأخبار المقالات

العنوان: Lexicon Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.